Objectives The aim of the study was to detect the prevalence of antibodies
against hepatitis A, B, C, and E viruses in flying airline personnel, and t
o determine the necessity of hepatitis A vaccination to prevent such infect
ions related to occupational exposure. Methods: Antibodies against hepatiti
s A (HAV), B (HBV), C (HVC), and E (HEV) were tested for using standard enz
yme immunoassay in airline personnel, 208 flying personnel, 199 ground crew
, and 204 employees from companies not involved in travel activities. Resul
ts: Prevalence of antibodies against HAV was less than 5% in each group, an
d there was no significant difference between the three groups. Prevalence
of antibodies against HEV was significantly higher in flying personnel (3.4
%) than in the control groups. Prevalence of antibodies against HBV and HCV
was low in each of the three groups and there were no differences between
the three groups. Conclusions: Infection with HAV, HBV and HCV does not see
m to represent an occupational hazard to flying personnel. It is possible t
hat flying personnel are exposed to infection with HEV, however, presently
no vaccine is available. Keywords: hepatitis virus infection, serosurvey, a
ntibody, aircrew, occupational hazard, travel medicine.